サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は非小細胞肺がんの治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは非小細胞肺がんの治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の非小細胞肺がんの治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは非小細胞肺がんの治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に非小細胞肺がんの治療市場を分類しています。本研究に含まれる主な企業は：Novartis AG、Pfizer Inc、Sanofi、F. Hoffmann-La Roche Ltd、Astrazeneca、Eli Lilly and Company、Merck & Co Inc、Bristol-Myers Squibb Company、Celgene Corporation

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Chemotherapy
    Targeted Therapy
    Immunotherapy

用途別の市場セグメント：
    Hospital
    Clinic
    Others

本レポートの詳細内容
世界の非小細胞肺がんの治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、非小細胞肺がんの治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の非小細胞肺がんの治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の非小細胞肺がんの治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、非小細胞肺がんの治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

非小細胞肺がんの治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：非小細胞肺がんの治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：非小細胞肺がんの治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章非小細胞肺がんの治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：非小細胞肺がんの治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：非小細胞肺がんの治療の主要企業の概要を提供し、製品の説明と仕様、非小細胞肺がんの治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Non Small Cell Lung Cancer Treatment Market
The global Non Small Cell Lung Cancer Treatment market is projected to grow from US$ 153 million in 2024 to US$ 260.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Non Small Cell Lung Cancer Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Non Small Cell Lung Cancer Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non Small Cell Lung Cancer Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non Small Cell Lung Cancer Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Non Small Cell Lung Cancer Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Non Small Cell Lung Cancer Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Novartis AG
    Pfizer Inc
    Sanofi
    F. Hoffmann-La Roche Ltd
    Astrazeneca
    Eli Lilly and Company
    Merck & Co Inc
    Bristol-Myers Squibb Company
    Celgene Corporation

Segment by Type
    Chemotherapy
    Targeted Therapy
    Immunotherapy

Segment by Application
    Hospital
    Clinic
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Non Small Cell Lung Cancer Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non Small Cell Lung Cancer Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non Small Cell Lung Cancer Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Targeted Therapy
    Table 4. Key Players of Immunotherapy
    Table 5. Global Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Non Small Cell Lung Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Non Small Cell Lung Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Non Small Cell Lung Cancer Treatment Market Share by Region (2019-2024)
    Table 9. Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Non Small Cell Lung Cancer Treatment Market Share by Region (2025-2030)
    Table 11. Non Small Cell Lung Cancer Treatment Market Trends
    Table 12. Non Small Cell Lung Cancer Treatment Market Drivers
    Table 13. Non Small Cell Lung Cancer Treatment Market Challenges
    Table 14. Non Small Cell Lung Cancer Treatment Market Restraints
    Table 15. Global Non Small Cell Lung Cancer Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Non Small Cell Lung Cancer Treatment Revenue Share by Players (2019-2024)
    Table 17. Global Top Non Small Cell Lung Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Small Cell Lung Cancer Treatment as of 2023)
    Table 18. Global Non Small Cell Lung Cancer Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Non Small Cell Lung Cancer Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Non Small Cell Lung Cancer Treatment, Headquarters and Area Served
    Table 21. Global Key Players of Non Small Cell Lung Cancer Treatment, Product and Application
    Table 22. Global Key Players of Non Small Cell Lung Cancer Treatment, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Non Small Cell Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Type (2019-2024)
    Table 26. Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Type (2025-2030)
    Table 28. Global Non Small Cell Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Non Small Cell Lung Cancer Treatment Revenue Share by Application (2019-2024)
    Table 30. Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Non Small Cell Lung Cancer Treatment Revenue Share by Application (2025-2030)
    Table 32. North America Non Small Cell Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Non Small Cell Lung Cancer Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Non Small Cell Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Non Small Cell Lung Cancer Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Non Small Cell Lung Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Non Small Cell Lung Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Non Small Cell Lung Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Non Small Cell Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Non Small Cell Lung Cancer Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Non Small Cell Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Non Small Cell Lung Cancer Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Non Small Cell Lung Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Non Small Cell Lung Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Non Small Cell Lung Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Non Small Cell Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Non Small Cell Lung Cancer Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Non Small Cell Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Non Small Cell Lung Cancer Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Non Small Cell Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Non Small Cell Lung Cancer Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Non Small Cell Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Non Small Cell Lung Cancer Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Non Small Cell Lung Cancer Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Non Small Cell Lung Cancer Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Non Small Cell Lung Cancer Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Novartis AG Company Details
    Table 65. Novartis AG Business Overview
    Table 66. Novartis AG Non Small Cell Lung Cancer Treatment Product
    Table 67. Novartis AG Revenue in Non Small Cell Lung Cancer Treatment Business (2019-2024) & (US$ Million)
    Table 68. Novartis AG Recent Developments
    Table 69. Pfizer Inc Company Details
    Table 70. Pfizer Inc Business Overview
    Table 71. Pfizer Inc Non Small Cell Lung Cancer Treatment Product
    Table 72. Pfizer Inc Revenue in Non Small Cell Lung Cancer Treatment Business (2019-2024) & (US$ Million)
    Table 73. Pfizer Inc Recent Developments
    Table 74. Sanofi Company Details
    Table 75. Sanofi Business Overview
    Table 76. Sanofi Non Small Cell Lung Cancer Treatment Product
    Table 77. Sanofi Revenue in Non Small Cell Lung Cancer Treatment Business (2019-2024) & (US$ Million)
    Table 78. Sanofi Recent Developments
    Table 79. F. Hoffmann-La Roche Ltd Company Details
    Table 80. F. Hoffmann-La Roche Ltd Business Overview
    Table 81. F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Product
    Table 82. F. Hoffmann-La Roche Ltd Revenue in Non Small Cell Lung Cancer Treatment Business (2019-2024) & (US$ Million)
    Table 83. F. Hoffmann-La Roche Ltd Recent Developments
    Table 84. Astrazeneca Company Details
    Table 85. Astrazeneca Business Overview
    Table 86. Astrazeneca Non Small Cell Lung Cancer Treatment Product
    Table 87. Astrazeneca Revenue in Non Small Cell Lung Cancer Treatment Business (2019-2024) & (US$ Million)
    Table 88. Astrazeneca Recent Developments
    Table 89. Eli Lilly and Company Company Details
    Table 90. Eli Lilly and Company Business Overview
    Table 91. Eli Lilly and Company Non Small Cell Lung Cancer Treatment Product
    Table 92. Eli Lilly and Company Revenue in Non Small Cell Lung Cancer Treatment Business (2019-2024) & (US$ Million)
    Table 93. Eli Lilly and Company Recent Developments
    Table 94. Merck & Co Inc Company Details
    Table 95. Merck & Co Inc Business Overview
    Table 96. Merck & Co Inc Non Small Cell Lung Cancer Treatment Product
    Table 97. Merck & Co Inc Revenue in Non Small Cell Lung Cancer Treatment Business (2019-2024) & (US$ Million)
    Table 98. Merck & Co Inc Recent Developments
    Table 99. Bristol-Myers Squibb Company Company Details
    Table 100. Bristol-Myers Squibb Company Business Overview
    Table 101. Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Product
    Table 102. Bristol-Myers Squibb Company Revenue in Non Small Cell Lung Cancer Treatment Business (2019-2024) & (US$ Million)
    Table 103. Bristol-Myers Squibb Company Recent Developments
    Table 104. Celgene Corporation Company Details
    Table 105. Celgene Corporation Business Overview
    Table 106. Celgene Corporation Non Small Cell Lung Cancer Treatment Product
    Table 107. Celgene Corporation Revenue in Non Small Cell Lung Cancer Treatment Business (2019-2024) & (US$ Million)
    Table 108. Celgene Corporation Recent Developments
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Non Small Cell Lung Cancer Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Chemotherapy Features
    Figure 4. Targeted Therapy Features
    Figure 5. Immunotherapy Features
    Figure 6. Global Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Non Small Cell Lung Cancer Treatment Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Others Case Studies
    Figure 11. Non Small Cell Lung Cancer Treatment Report Years Considered
    Figure 12. Global Non Small Cell Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Non Small Cell Lung Cancer Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Non Small Cell Lung Cancer Treatment Market Share by Region: 2023 VS 2030
    Figure 15. Global Non Small Cell Lung Cancer Treatment Market Share by Players in 2023
    Figure 16. Global Top Non Small Cell Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Small Cell Lung Cancer Treatment as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Non Small Cell Lung Cancer Treatment Revenue in 2023
    Figure 18. North America Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Non Small Cell Lung Cancer Treatment Market Share by Type (2019-2030)
    Figure 20. North America Non Small Cell Lung Cancer Treatment Market Share by Application (2019-2030)
    Figure 21. North America Non Small Cell Lung Cancer Treatment Market Share by Country (2019-2030)
    Figure 22. United States Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Non Small Cell Lung Cancer Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Non Small Cell Lung Cancer Treatment Market Share by Type (2019-2030)
    Figure 26. Europe Non Small Cell Lung Cancer Treatment Market Share by Application (2019-2030)
    Figure 27. Europe Non Small Cell Lung Cancer Treatment Market Share by Country (2019-2030)
    Figure 28. Germany Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Non Small Cell Lung Cancer Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Non Small Cell Lung Cancer Treatment Market Share by Type (2019-2030)
    Figure 36. China Non Small Cell Lung Cancer Treatment Market Share by Application (2019-2030)
    Figure 37. Asia Non Small Cell Lung Cancer Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Non Small Cell Lung Cancer Treatment Market Share by Type (2019-2030)
    Figure 39. Asia Non Small Cell Lung Cancer Treatment Market Share by Application (2019-2030)
    Figure 40. Asia Non Small Cell Lung Cancer Treatment Market Share by Region (2019-2030)
    Figure 41. Japan Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Non Small Cell Lung Cancer Treatment Market Share by Country (2019-2030)
    Figure 51. Brazil Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Novartis AG Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2019-2024)
    Figure 58. Pfizer Inc Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2019-2024)
    Figure 59. Sanofi Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2019-2024)
    Figure 60. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2019-2024)
    Figure 61. Astrazeneca Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2019-2024)
    Figure 62. Eli Lilly and Company Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2019-2024)
    Figure 63. Merck & Co Inc Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2019-2024)
    Figure 64. Bristol-Myers Squibb Company Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2019-2024)
    Figure 65. Celgene Corporation Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed